PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
+4.69%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$4.12B
AUM Growth
+$4.12B
(+12%)
Cap. Flow
+$490M
Cap. Flow
% of AUM
11.9%
Top 10 Holdings %
Top 10 Hldgs %
35.31%
Holding
108
New
19
Increased
30
Reduced
27
Closed
22
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
$203M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$178M |
| 3 |
Gilead Sciences
GILD
|
$92.2M |
| 4 |
Sarepta Therapeutics
SRPT
|
$83.1M |
| 5 |
Alibaba
BABA
|
$65.9M |
Top Sells
| 1 |
UnitedHealth
UNH
|
$95.3M |
| 2 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$83.7M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
$77.2M |
| 4 |
Pfizer
PFE
|
$52M |
| 5 |
Elevance Health
ELV
|
$44.4M |
Sector Composition
| 1 | Healthcare | 70.69% |
| 2 | Technology | 11.2% |
| 3 | Communication Services | 5.11% |
| 4 | Consumer Discretionary | 4.12% |
| 5 | Financials | 2.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Intuit
INTU
$186B
| $56.9M | 1.08% | 217,747 -34,792 | -14% | -$9.09M |
|
27
Walt Disney
DIS
$213B
| $55.7M | 1.06% | +398,702 | New | +$55.7M |
|
28
GoDaddy
GDDY
$20.5B
| $54.9M | 1.04% | 782,442 -291,975 | -27% | -$20.5M |
|
29
iRhythm Technologies
IRTC
$5.46B
| $54M | 1.03% | 682,963 +140,930 | +26% | +$11.1M |
|
30
Microsoft
MSFT
$3.77T
| $53.9M | 1.02% | 402,579 +106,279 | +36% | +$14.2M |
|
|
NVRO
31
DELISTED
NEVRO CORP.
NVRO
| $53.9M | 1.02% | 830,834 +109,605 | +15% | +$7.11M |
|
|
32
Elevance Health
ELV
$71.8B
| $53.4M | 1.01% | 189,219 -157,178 | -45% | -$44.4M |
|
33
Progressive
PGR
$145B
| $52.2M | 0.99% | +653,485 | New | +$52.2M |
|
34
Exact Sciences
EXAS
$8.98B
| $49.4M | 0.94% | 418,329 -148,030 | -26% | -$17.5M |
|
35
Thermo Fisher Scientific
TMO
$186B
| $47.2M | 0.9% | 160,666 -120,770 | -43% | -$35.5M |
|
|
TWTR
36
DELISTED
Twitter, Inc.
TWTR
| $45M | 0.85% | +1,288,027 | New | +$45M |
|
37
Twilio
TWLO
$16.2B
| $43.1M | 0.82% | 316,142 +190,387 | +151% | +$26M |
|
38
Align Technology
ALGN
$10.3B
| $42.5M | 0.81% | 155,459 -57,430 | -27% | -$15.7M |
|
39
New York Times
NYT
$9.74B
| $42.5M | 0.81% | 1,301,486 -426,365 | -25% | -$13.9M |
|
40
Netflix
NFLX
$513B
| $38.8M | 0.74% | 105,639 +19,219 | +22% | +$7.06M |
|
|
DERM
41
DELISTED
Dermira, Inc.
DERM
| $38.7M | 0.73% | 4,044,542 +1,463,509 | +57% | +$14M |
|
42
Sea Limited
SE
$110B
| $38.4M | 0.73% | 1,155,123 +147,154 | +15% | +$4.89M |
|
43
Puma Biotechnology
PBYI
$254M
| $36.1M | 0.69% | 2,838,376 +234,456 | +9% | +$2.98M |
|
|
XYZ
44
Block, Inc.
XYZ
$48.5B
| $35.3M | 0.67% | 487,346 -88,252 | -15% | -$6.4M |
|
|
WMGI
45
DELISTED
Wright Medical Group Inc
WMGI
| $35.3M | 0.67% | 1,183,313 +273,123 | +30% | +$8.14M |
|
46
Trip.com Group
TCOM
$48.2B
| $34.2M | 0.65% | 927,160 +547,650 | +144% | +$20.2M |
|
|
CTLT
47
DELISTED
CATALENT, INC.
CTLT
| $33.4M | 0.64% | +617,019 | New | +$33.4M |
|
48
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $32.2M | 0.61% | 1,457,985 +510,924 | +54% | +$11.3M |
|
49
Pacira BioSciences
PCRX
$1.2B
| $31.9M | 0.61% | 734,346 +452,149 | +160% | +$19.7M |
|
50
Fate Therapeutics
FATE
$120M
| $31.4M | 0.6% | 1,547,730 +266,194 | +21% | +$5.4M |
|